Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Changrui Enema Powder for Chronic Radiation Proctitis
CTR20201391Phase 2Active
- Sponsor
- Shanxi Zhendong Pharmaceutical Co., Ltd.
- Start
- Jul 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of Changrui Guanchang San in chronic radiation proctitis (CRP), sponsored by Shanxi Zhendong Pharmaceutical Co., Ltd.. Started Jul 2020; status: active.
02
Drugs
Changrui Guanchang San
03
Conditions
chronic radiation proctitis (CRP)
Beyond the preview
Go deeper on CTR20201391.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20201391.